Contraceptive Use and Missed Opportunities for Family Planning Discussions in Women Living with Human Immunodeficiency Virus at an HIV Clinic.
Ashley WintersBernadette JakemanKelsea Gallegos AragonZoe KastenAlexander J BosJeremy SnyderAlexandra HermanPublished in: Journal of the International Association of Providers of AIDS Care (2022)
The objective of this study was to examine contraception use and family planning discussions (FPD) in female people living with HIV (PLWH). A retrospective cohort study was conducted. Female PLWH were included if they were 18-44 years and received care in 2019 at an HIV clinic. 74 patients met inclusion; mean age was 35 years, 53% were white. All patients were prescribed antiretroviral therapy. 48.6% of patients had documented FPD. 64.9% of patients were using contraception; sterilization was most common (41.7%). Only five patients had a contraindication to hormonal contraception. No differences in contraception use were observed based on age, race, HIV viral load, number of visits, or past pregnancies. However, patients with documented FPD were more likely to use contraception (OR 4.55; 95% CI 1.35-15.29). Routine FPD and contraception use in female PLWH were low. Rates of sterilization were high in female PLWH. Providing quality family planning services is critical to increase contraception use and selection of the most appropriate contraception form.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- hiv infected
- hepatitis c virus
- peritoneal dialysis
- primary care
- hiv positive
- prognostic factors
- hiv aids
- palliative care
- quality improvement
- patient reported outcomes
- skeletal muscle
- polycystic ovary syndrome
- clinical practice
- adipose tissue